Evaluation of Somatic Mutation Spectrum as Biomarker for Survival Outcome in Chinese CRC

ABSTRACT: By analyse the tissue/blood variant spectrum model using NGS, the present clinical trial aims to elucidate the genetic basis of CRC in Chinese; to establish of CRC genetic map in Chinese patients; to identification new genetic biomarkers, drug and pathways; and to subtyping for precision treatment and management for Chinese CRC patients.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2326961 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR